Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Vietnam determined to save British pilot, avoid its first COVID-19 death

Published 05/14/2020, 03:16 AM
Updated 05/14/2020, 03:20 AM

By James Pearson (NYSE:PSO)

HANOI (Reuters) - Vietnam has mounted an all-out effort to save the life of its most critically ill novel coronavirus patient, a British pilot who works for Vietnam Airlines, the national carrier.

Through aggressive testing and a mass, centralised quarantine programme, the Southeast Asian country has kept its tally of coronavirus cases to just 288 and has reported no deaths.

Little expense has been spared to try save the life of the 43-year-old man, identified only as "Patient 91", who caught the coronavirus at a bar in the southern business hub of Ho Chi Minh City in mid-March, state media reported.

More than 4,000 people connected to the cluster were tested, with 18 of them found to be infected with the coronavirus.

While most have recovered, the British pilot is on life support and his condition has deteriorated significantly.

On Tuesday, the health ministry held a meeting with experts from top hospitals and decided that the only way to save the man's life was with a lung transplant.

His case has garnered national interest in Vietnam, where the government has won broad support for its campaign to contain the coronavirus.

On Thursday, state media said 10 people, including a 70-year-old military veteran, had volunteered themselves as lung donors, but had been turned down by state doctors.

"We are touched by their good intentions, but current regulations don't allow us to transplant lungs donated by most living people," a representative of the Vietnam National Coordinating Centre for Human Organ Transplantation (VNHOT) told the Tuoi Tre newspaper.

The patient has just 10% of his lung capacity left and has been on life support for more than 30 days, Tuoi Tre said.

Deputy health minister Nguyen Truong Son told media last month that Vietnam had imported specialist medicine from overseas to treat blood clots in the patient, but to no avail.

Vietnam has spent more than 5 billion dong ($200,000) trying to save him, the Vietnam News Agency (VNA) reported.

In March, Chinese state media said it had successfully carried out a double lung transplant on a coronavirus patient, a procedure it hailed as a significant method of treating the disease's most stricken victims.

Vietnam is hoping to capitalise on its success fighting the coronavirus by positioning itself as a safe place to do business as international manufacturers look to diversify their supply chains away from China.

($1 = 23,365.0000 dong)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.